The pharmaceutical industry operates in an environment where quality, compliance, cost efficiency and customer trust are critical to business success. For B2B pharmaceutical companies, improving internal processes is not simply about reducing costs—it is about building a reliable, scalable and resilient business.
Whether you are a pharmaceutical manufacturer, API producer, CDMO, contract manufacturer, laboratory, packaging supplier or healthcare B2B service provider, operational excellence can create measurable business value.
By combining ISO 9001 principles, Lean Six Sigma, structured problem solving and ESG practices, organisations can reduce waste, improve consistency, strengthen customer relationships and prepare for international markets.
Why Operational Excellence Matters in B2B Pharma
B2B pharmaceutical companies often operate across complex supply chains involving:
- Raw-material suppliers
- API manufacturers
- Formulation manufacturers
- Contract development and manufacturing organisations
- Quality-control laboratories
- Packaging suppliers
- Distributors
- Regulatory and compliance teams
- International customers
A problem at one stage can affect multiple downstream activities.
For example, a delay in raw-material approval can affect production scheduling, which can lead to delayed batch release, missed customer delivery commitments and additional logistics costs.
Operational excellence focuses on identifying these process weaknesses and systematically improving them.
1. Use Lean to Reduce Waste
Lean methodology focuses on identifying activities that consume resources without creating corresponding customer value.
In a pharmaceutical B2B environment, waste can appear as:
- Excessive approvals
- Duplicate documentation
- Waiting for quality decisions
- Repeated data entry
- Unnecessary movement of materials
- Excess inventory
- Rework and deviations
- Delayed batch release
- Over-processing
- Underutilisation of employee expertise
Example: Reducing Batch Release Delays
Imagine a pharmaceutical manufacturer where a completed batch requires multiple quality checks before release.
If the process requires samples to move between departments, documents to be manually verified and approvals to pass through several levels, the batch may spend considerable time waiting.
A Lean review could map the entire process from manufacturing completion to final release.
The current process might look like:
Manufacturing → Sampling → Testing → Documentation Review → QA Review → Approval → Release
The analysis may reveal that some activities can be performed in parallel rather than sequentially.
The objective is not simply to make people work faster. It is to redesign the process so that unnecessary waiting and duplication are removed.
2. Apply Six Sigma to Reduce Process Variation
Lean focuses heavily on waste and flow. Six Sigma adds a strong emphasis on variation, measurement and data-driven problem solving.
For B2B pharma companies, variation can affect:
- Manufacturing processes
- Testing turnaround time
- Delivery performance
- Customer complaints
- Packaging quality
- Documentation accuracy
- Supplier performance
- Batch consistency
Example: Customer Complaints
Suppose a B2B pharmaceutical supplier receives repeated complaints about packaging defects.
Instead of treating each complaint independently, the organisation can collect data and analyse the pattern.
| Month | Packaging Complaints |
|---|---|
| January | 8 |
| February | 10 |
| March | 12 |
| April | 11 |
| May | 15 |
The organisation could use DMAIC—Define, Measure, Analyse, Improve and Control—to investigate the problem.
Possible causes might include:
- Supplier variation
- Machine settings
- Operator practices
- Packaging-material specifications
- Environmental conditions
- Inspection methods
The objective is to identify the underlying cause rather than repeatedly correcting the symptom.
3. Use Root Cause Analysis Instead of Treating Symptoms
In pharmaceutical operations, recurring problems can consume significant management time.
A deviation occurs. A corrective action is implemented. The issue appears again.
This can happen when the organisation addresses the immediate cause rather than the systemic root cause.
Example: Repeated Documentation Errors
Suppose a pharmaceutical company experiences repeated errors in batch documentation.
A superficial corrective action might be:
“Retrain the employee.”
But a structured root-cause analysis should also ask:
- Is the procedure clear?
- Are forms unnecessarily complicated?
- Are instructions available at the point of use?
- Is the workload creating time pressure?
- Are there multiple versions of the same document?
- Is the electronic system generating confusing fields?
- Is the process vulnerable to human error?
Tools such as 5 Whys and Fishbone Analysis can help teams explore these possibilities systematically.
The resulting improvement may involve redesigning the process rather than simply retraining employees.
4. ISO 9001 as a Foundation for Process Management
ISO 9001 provides a structured approach to quality management.
For B2B pharma companies, ISO 9001 can support areas such as:
- Process management
- Customer focus
- Risk-based thinking
- Documented information
- Supplier management
- Performance evaluation
- Corrective action
- Continual improvement
ISO 9001 should not be viewed merely as a certification exercise.
Its greatest value can come from using the underlying principles to create repeatable and controlled business processes.
For example, a pharmaceutical supplier serving international customers could use process mapping and performance indicators to understand how effectively it handles:
Customer enquiry → Quotation → Technical evaluation → Order → Production → Quality release → Documentation → Dispatch → Customer feedback
This provides management with a clearer view of where delays, errors and risks occur.
5. ESG Is Becoming Relevant to Pharma Supply Chains
Environmental, social and governance considerations are increasingly relevant to companies operating across international B2B supply chains.
Pharmaceutical organisations may need to consider areas such as:
Environmental
- Energy consumption
- Water use
- Waste management
- Emissions
- Sustainable packaging
- Resource efficiency
Social
- Employee safety
- Training
- Labour practices
- Supplier standards
- Community impact
- Workplace wellbeing
Governance
- Business ethics
- Compliance
- Risk management
- Data governance
- Transparency
- Accountability
For B2B companies, ESG can increasingly become part of how customers evaluate suppliers.
6. Real-World Example: API Manufacturer
Consider an API manufacturer supplying pharmaceutical companies in several countries.
The company experiences:
- High inventory levels
- Long production lead times
- Repeated equipment downtime
- High energy consumption
- Customer pressure for shorter delivery times
A combined improvement programme could address the problem from several angles.
Lean: Map material and information flow to identify waiting and unnecessary movement.
Six Sigma: Analyse production data to identify sources of process variation.
Root Cause Analysis: Investigate recurring equipment failures.
ESG: Measure energy and resource consumption associated with production.
ISO 9001: Strengthen process controls, monitoring and continual improvement.
Instead of treating each issue as an isolated problem, management can create an integrated improvement programme.
7. Real-World Example: Pharmaceutical CDMO
A CDMO may manage multiple customers with different products, specifications, documentation requirements and production schedules.
One common business challenge is balancing:
Customer requirements + production capacity + quality requirements + delivery commitments.
A Value Stream Mapping exercise can help identify where time is being consumed between:
Customer order → Technical review → Planning → Material procurement → Manufacturing → Testing → QA review → Batch release → Dispatch
The organisation can then identify bottlenecks and establish relevant KPIs.
Possible KPIs include:
- On-time delivery
- Batch release cycle time
- Right-first-time percentage
- Deviation rate
- Customer complaint rate
- Equipment utilisation
- Inventory days
- Supplier performance
The goal is to make improvement measurable.
8. Real-World Example: Pharmaceutical Packaging Supplier
A packaging supplier may produce bottles, blister packs, labels or other pharmaceutical packaging components.
Suppose customers report inconsistent delivery performance.
Rather than simply increasing inventory, the company could analyse the entire order-to-delivery process.
Potential causes could include:
- Production scheduling issues
- Supplier delays
- Machine changeover time
- Quality inspection queues
- Poor demand visibility
- Manual order processing
A combination of Lean, process mapping and data analysis can help identify the largest contributors to delivery delays.
The improvement programme can then target the specific bottleneck rather than applying a generic solution.
9. Turning Improvement Into Business Value
The ultimate objective of operational excellence is not simply to create better-looking processes.
It is to create measurable business outcomes.
Depending on the organisation, these may include:
- Lower operating costs
- Shorter lead times
- Fewer defects
- Reduced rework
- Improved customer satisfaction
- Better delivery performance
- Lower inventory
- Improved productivity
- Reduced resource consumption
- Stronger supplier performance
- Greater operational resilience
For B2B pharma companies, these improvements can also strengthen the organisation’s ability to serve demanding domestic and international customers.
10. Build a Culture of Continual Improvement
Tools alone do not create operational excellence.
People do.
A successful improvement culture encourages employees to identify problems, use evidence to understand them and participate in developing solutions.
This is where Kaizen and continual improvement become important.
Instead of waiting for major transformation projects, organisations can encourage teams to make smaller, measurable improvements continually.
A simple improvement cycle can be:
Identify → Measure → Analyse → Improve → Control → Repeat
Over time, these improvements can contribute to significant operational gains.
How B2B Pharma Companies Can Start
A practical starting point is to select one business-critical process rather than attempting to transform the entire organisation simultaneously.
- Select a process with a measurable business problem.
- Define the problem and customer impact.
- Map the current process.
- Collect baseline data.
- Identify waste and variation.
- Investigate root causes.
- Develop improvement actions.
- Measure the results.
- Standardise successful changes.
- Continue monitoring performance.
This approach creates a connection between quality management, operational improvement and business strategy.
Ask Aditee
Have a question about ISO 9001, ESG, global markets or business growth?
Ask Aditee for practical insights and perspectives to help you navigate quality, sustainability and international business opportunities.
ISO & Quality
Questions about ISO 9001, quality management systems, auditing, process improvement and continual improvement.
ESG & Sustainability
Understand ESG considerations, sustainability practices and how responsible business can support long-term value creation.
Global Markets
Explore international market opportunities, market-entry considerations, customer expectations and global business development.
Growth & Strategy
Get practical perspectives on business growth, operational improvement, market positioning and sustainable competitive advantage.
Have a Question?
Send your question and get a practical perspective from Aditee.
Expert FAQs: Mandar & Aditee Answer Your Questions
What is Lean Six Sigma in the pharmaceutical industry?
Lean Six Sigma combines Lean methods for reducing waste with Six Sigma methods for reducing process variation. In pharmaceutical businesses, it can be applied to manufacturing, quality, supply chain, documentation, laboratories, customer service and other processes.
Can Lean Six Sigma be used by B2B pharmaceutical companies?
Yes. Lean Six Sigma can be applied across pharmaceutical manufacturers, API companies, CDMOs, laboratories, packaging suppliers, distributors and other B2B organisations.
How does ISO 9001 help pharmaceutical companies?
ISO 9001 provides a framework for managing processes, customer requirements, risks, performance and continual improvement. It can complement industry-specific pharmaceutical quality and regulatory requirements rather than replacing them.
What is DMAIC?
DMAIC stands for Define, Measure, Analyse, Improve and Control. It is a structured methodology used to investigate problems, identify causes, implement improvements and sustain results.
What is Value Stream Mapping?
Value Stream Mapping is a Lean technique used to visualise the flow of materials, information and activities through a process. It can help identify waiting, bottlenecks, unnecessary steps and other sources of waste.
How can ESG create value for a pharmaceutical company?
ESG initiatives can help organisations manage environmental and social impacts while strengthening governance and risk management. For B2B companies, ESG practices can also become relevant to customer, investor and supply-chain requirements.
What is the difference between Lean and Six Sigma?
Lean primarily focuses on improving flow and eliminating waste, while Six Sigma focuses strongly on reducing variation and improving process performance through data. Organisations often use the two approaches together.
How can a pharmaceutical company measure operational excellence?
Useful measures can include lead time, on-time delivery, defect rates, rework, customer complaints, batch release time, inventory levels, equipment downtime, productivity and resource consumption.
Does operational excellence only apply to manufacturing?
No. B2B pharma companies can apply operational excellence to procurement, quality, regulatory affairs, finance, customer service, supply chain, laboratories, documentation and other business processes.
Conclusion
For B2B pharmaceutical companies, operational excellence is increasingly about connecting quality, efficiency, data, sustainability and business growth.
Lean can help organisations identify waste. Six Sigma can help reduce variation. Root Cause Analysis can help address recurring problems. ISO 9001 can provide a structured quality-management framework, while ESG can help organisations address broader environmental, social and governance expectations.
The real opportunity comes from bringing these approaches together and applying them to real business problems with measurable outcomes.
Better processes create better performance—and better performance creates sustainable business value.
About the Authors
Mandar Pandit
Founder & Director | Lean Six Sigma, ISO & Risk Advisory Expert
Mandar Pandit is a management and operational excellence professional specialising in Lean Six Sigma, ISO management systems, risk advisory and business process improvement.As Founder & Director, he works with organisations to strengthen processes, improve operationalperformance, manage risk and build sustainable improvement capabilities.
His approach combines structured problem-solving methodologies with practical business thinking,helping organisations translate quality and process improvement initiatives into measurable
business outcomes.
Aditee Shekdar
ISO 9001 Lead Auditor | ESG Consultant | Global Markets & Growth Advisor
Aditee Shekdar is an ISO 9001 Lead Auditor, ESG Consultant and Global Markets & Growth Advisor Her work focuses on helping organisations strengthen quality practices,understand ESG considerations and identify opportunities for sustainable growth across domestic
and international markets.
With a focus on quality, sustainability and business growth, she brings a strategic perspective to organisations seeking to improve performance while responding to evolving customer, market and stakeholder expectations.
